Tilorone 125 mg – [6 tablets]

Low-molecular synthetic inducer of interferon, stimulating the formation of interferon alpha, beta, gamma and lambda in the body. The main producers of interferon in response to tiloron administration are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration the maximum production of interferon is determined in the sequence intestine – liver – blood in 4-24 hours. Tiloron has immunomodulatory and antiviral effects. After a single oral administration of Tiloron at a dose equivalent to the maximum daily dose for humans, the maximum concentration in the lung tissue of interferon lambda was determined after 24 hours, interferon alpha – after 48 hours. Induction of interferon lambda in the lung tissue contributes to an increase in the antiviral protection of the respiratory tract during influenza and other respiratory viral infections. In human leukocytes induces the synthesis of interferon. It stimulates bone marrow stem cells, and, depending on the dose, enhances antibody production, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers. Effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpesviruses. The mechanism of antiviral action is associated with inhibition of translation of virus-specific proteins in infected cells, resulting in suppression of virus reproduction.

As part of complex therapy:

In children from 7 to 18 years:

– Treatment of influenza and other acute respiratory viral infections (ARI).

In adults:

– Treatment of influenza and other acute respiratory viral infections;

– Treatment of herpetic infections. Prevention of influenza and other acute respiratory viral infections in adults

– Hypersensitivity to Tyloron and other components of the drug.

– Pregnancy and lactation

– Childhood age under 7 years old.

– hereditary lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

Caution: As part of the complex therapy of infectious-allergic and viral encephalomyelitis, the drug is used under medical supervision.

Administration during pregnancy and lactation

The drug is contraindicated during pregnancy. If it is necessary to prescribe the drug during lactation, breastfeeding must be stopped.